DashboardAll companies
Run this on your own research
Common Stock · Common Stock

Peptron Inc.

087010KRX₩92,300−₩4,900 (−5.04%)Market closed

Price Chart

Daily

Key facts

Market Cap
₩2.15T
P/E
−155.1x
P/B
15.10x
ROE
−9.4%

Peptron Inc.

Common Stock · Common Stock · FY 2025

Peptron Inc. is a biotechnology company specializing in the development and manufacturing of pharmaceutical products with a focus on peptide-based therapies. Its primary function is to innovate in long-acting peptide formulations, enhancing the delivery and efficacy of therapeutic solutions for various medical conditions. The company's products are utilized across a spectrum of medical sectors, including endocrinology, oncology, and neurology, offering potentially transformative treatments for chronic diseases. Peptron Inc. also engages in collaborative research and development efforts, frequently partnering with academic institutions and other biotech firms to advance the scope and impact of its technologies. In the financial market, Peptron Inc. is recognized for its contributions to the biopharmaceutical sector, reflecting its commitment to pioneering treatment solutions and its potential in influencing future healthcare advancements.

CEO
최호일
Employees
0

Company Statistics

Valuation

P/E
−155.1x
P/B
15.10x
P/S
380.57x
EV/EBITDA
−153.2x
P/FCF
−90.9x

Margins

Gross
27.2%
EBITDA
−251.3%
Operating
−377.3%
Pre-Tax
−254.3%
Net
−245.3%

Returns

ROA
−7.9%
ROE
−9.4%
ROIC
−7.5%

Growth (CAGR)

Rev 3Yr
−1.0%
Rev 5Yr
12.5%
Op Inc 3Yr
—
Net Inc 3Yr
—

Financial Health

Cash & Cash Equivalents
₩4.38B
Net Debt
₩32.59B
Debt/Equity
26.0%
Interest Cov
—

Profile

Revenue
₩5.63B
Shares Out
23.3M
Public markets · Korea, US, Japanalpha-lenz.com · Core by Treasurer
Peptron Inc. (087010) Stock Forecast 2026 ₩92,300 — Price, Financials & Analyst Targets | AlphaLenz